Cargando…
RBMS3, a downstream target of AMPK, Exerts Inhibitory Effects on Invasion and Metastasis of Lung Cancer
Background: Lung cancer is a highly malignant disease, primarily due to its propensity for metastasis. AMP-activated protein kinase (AMPK), the principal downstream effector of Liver Kinase B1 (LKB1), orchestrates a broad spectrum of molecular targets, thereby constraining tumor invasion and metasta...
Autores principales: | Lv, Shi-Lin, Zhou, Xu, Li, Yuan-jun, Luo, Ling-yu, Huang, De-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539560/ https://www.ncbi.nlm.nih.gov/pubmed/37781074 http://dx.doi.org/10.7150/jca.86572 |
Ejemplares similares
-
LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth
por: Zhou, Jing, et al.
Publicado: (2011) -
RBMS3 Inhibits the Proliferation and Metastasis of Breast Cancer Cells
por: Yang, Yuan, et al.
Publicado: (2018) -
RBMS says farewell
por: Johnson, Martin, et al.
Publicado: (2022) -
The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression
por: Zhu, Lei, et al.
Publicado: (2019) -
Correction to: The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression
por: Zhu, Lei, et al.
Publicado: (2020)